I
Power Law company profile
Idorsia
Biotech & Life Sciences · Allschwil, Switzerland · Founded 2017 · IPO 2017 Unicorn
Valuation
$1.97B
Market cap · Apr/2026
Revenue
$202M
Latest reported FY
Global footprint
Where Idorsia has talent and traffic
AI talent share
1.0%
of workforce is AI talent
(7 of 726 staff)
(7 of 726 staff)
Core AI10.14%
Other AI60.83%
Non-AI workforce71999.04%
Web traffic by country
29K
monthly visits
across markets
across markets
🇨🇭 Switzerland49%
🇬🇧 United Kingdom23.1%
🇺🇸 United States14.5%
🇨🇦 Canada11%
🇫🇷 France7.2%
Patent intelligence
$693M patent portfolio · 303 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$693M
35.1% of market cap · comparable to top peer BioNTech ($780M)
303 active patent families
Where Idorsia innovates
Perylene derivativesMedicinal chemistryPharmaceutical SubstancesCombinatorial chemistryPharmacology
Below peer median on Legal, Market
Quality vs same-sector peers
Idorsia on the five Patsnap quality dimensions
Idorsia in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Idorsia concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Idorsia and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Idorsia on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.